Compounded vs FDA-Approved ED Meds: 2026 Safety Tracker

Introduction: A consumer question the FDA just answered

If you have shopped for erectile dysfunction medication online in the last two years, you have almost certainly seen ads for chewable “blue mints,” “hard mints,” or “stronger-than-Viagra” tablets at a fraction of the pharmacy price. Most of these are compounded — custom-mixed by a specialty pharmacy rather than mass-manufactured under FDA approval.

For most of the telehealth boom, the distinction was buried in fine print. Then, on September 9, 2025, the U.S. Food and Drug Administration sent warning letters to dozens of telehealth platforms accusing them of marketing compounded medications in ways that misled consumers about their regulatory status. The action put names like BlueChew and Hello Cake on the front page of health news — and left millions of subscribers asking a fair question: Is the ED medication I am taking actually safe?

This guide is our attempt to answer that question without shilling. We recommend FDA-approved options first because they have the strongest evidence base. We explain when compounded medication is a reasonable choice. And we maintain a live tracker of which major telehealth services dispense which type, so you can decide with your eyes open.

What does “FDA-approved” actually mean for ED medications?

When a medication is “FDA-approved,” it means the U.S. Food and Drug Administration has reviewed clinical trial data and concluded that, for a specific indication and dosage, the drug’s benefits outweigh its risks. Approval requires:

• Pre-market review of safety and efficacy data from controlled trials
• Manufacturing oversight under Current Good Manufacturing Practice (CGMP) regulations
• Bioequivalence testing for generics, ensuring the same active ingredient delivery as the brand
• Post-market surveillance for adverse events through MedWatch

For erectile dysfunction, FDA-approved options in the United States include:

• Branded PDE5 inhibitors: Viagra (sildenafil, Pfizer), Cialis (tadalafil, Eli Lilly), Levitra (vardenafil, Bayer/GSK), Stendra (avanafil, Metuchen)
• Generic PDE5 inhibitors: sildenafil, tadalafil, and vardenafil produced by approved manufacturers including Teva, Mylan (Viatris), Aurobindo, Hikma, Sun Pharma, and others

Any pharmacy filling a prescription for one of these — whether a corner CVS, a mail-order pharmacy, or a telehealth dispensary — is handing you an FDA-approved product. The pill came off a regulated manufacturing line and was tested for potency before it reached you.

What does “compounded” mean? 503A vs 503B pharmacies

Compounding is the practice of a licensed pharmacist combining, mixing, or altering drug ingredients to create a medication tailored to an individual patient’s needs. The legal framework lives in two sections of the Federal Food, Drug, and Cosmetic Act:

• Section 503A — Traditional compounding pharmacies. Compound on a per-patient basis in response to a valid prescription. Regulated primarily by state boards of pharmacy. May use bulk drug substances only under specific conditions.
• Section 503B — Outsourcing facilities. Register voluntarily with the FDA, follow CGMP standards similar to manufacturers, and may compound in larger batches without patient-specific prescriptions. Inspected by the FDA.

Both 503A and 503B compounded products are not individually FDA-approved. The FDA does not review the safety or efficacy of each compounded formulation. A 503B facility’s manufacturing process is inspected, but the specific compounded sildenafil tablet you receive has not gone through the new-drug approval process.

This is the key consumer takeaway: a compounded version of sildenafil is not a generic of Viagra. It is a custom formulation that uses sildenafil citrate as an active ingredient.

Are compounded ED medications legal in the US?

Yes — with caveats. Compounding is legal when a licensed prescriber determines a patient needs a customized formulation that is not commercially available. Classic legitimate use cases include:

• Allergy to an inactive ingredient (dye, gluten, lactose) in the FDA-approved version
• Need for a dose strength not commercially manufactured
• Need for an alternate dosage form (a child who cannot swallow tablets, for example)
• A documented FDA drug shortage allowing temporary expanded compounding

The FDA’s concern, expressed in its September 2025 letters, is not compounding itself. It is the use of compounding statutes to operate what regulators describe as de facto manufacturing of unapproved drugs — marketed direct-to-consumer at scale, often without a patient-specific clinical justification, and frequently without making the unapproved status clear to buyers.

What the September 2025 FDA warning letters say

On September 9, 2025, the FDA issued warning letters to roughly 58 telehealth firms. Two of the most widely covered targets in the ED category:

• Dermacare LLC dba BlueChew — cited for marketing chewable compounded sildenafil and tadalafil tablets in ways that the FDA alleged failed to adequately disclose the products are not FDA-approved.
• Hello Cake Inc dba Hello Cake — cited for similar marketing concerns around compounded ED products.
• MEDVi and approximately 55 other telehealth and compounding-affiliated companies received parallel letters covering compounded GLP-1s and ED products.

The agency’s stated concerns clustered around four themes:

1. Marketing compounded products without adequately disclosing they are not FDA-approved. Ads and landing pages emphasized convenience, price, and chewable formats while burying or omitting the regulatory distinction.
2. Implying clinical equivalence to brand-name or FDA-approved generics. The FDA emphasized that compounded sildenafil is not therapeutically interchangeable with FDA-approved sildenafil tablets.
3. Use of bulk drug substances outside the conditions Congress set in sections 503A and 503B.
4. Direct-to-consumer marketing at manufacturer scale while operating under statutes intended for patient-specific compounding.

A warning letter is not a recall and not a finding of harm to any specific patient. It is a formal notice of alleged violations that must be addressed, typically within 15 working days, and it puts the company on notice that enforcement action may follow.

Telehealth ED services: compounded vs FDA-approved at a glance

The table below summarizes what each major US ED telehealth service currently dispenses. Status reflects May 2026 information; specifics vary by product line within each service.

Why telehealth services use compounded medications

The compounded-medication boom is not random. From a business and clinical standpoint, several factors push platforms toward compounding:

• Cost. Compounded active pharmaceutical ingredient (API) sourced in bulk is dramatically cheaper than packaged FDA-approved tablets. That margin lets companies offer subscription pricing far below the retail cost of branded medication.
• Dosing flexibility. Generic sildenafil is sold in 20 mg, 50 mg, and 100 mg tablets. Compounding lets a service offer 30 mg, 45 mg, or 60 mg — useful for titration, also useful for marketing custom formulations.
• Dosage form. Chewables, dissolvable tablets, and flavored troches are not available as FDA-approved sildenafil products. Compounding makes them possible.
• Combination products. Combining sildenafil with tadalafil, or with adjuncts like oxytocin or L-arginine, is only possible through compounding. Whether these combinations are clinically advantageous is a separate question.

We mention these because dismissing all compounded products as scams is unfair to the legitimate uses of compounding. The FDA’s concern is not the existence of these formulations; it is the disclosure and scale of their marketing.

The real risks of compounded ED medications

Compounded medications skip the regulatory checkpoints that catch quality problems before they reach consumers. The documented risk categories include:

• No FDA pre-market review for the specific formulation’s safety and efficacy.
• Potency variability. Independent testing of compounded products has historically found tablets that were sub- or super-potent compared to the labeled dose. The United States Pharmacopeia (USP) sets standards (USP <795>, <797>, <800>) but compliance varies by pharmacy.
• Bulk drug substance sourcing. API sourced from overseas suppliers may or may not meet US pharmacopeial standards depending on the pharmacy’s verification process.
• Sterility and contamination risk — historically more relevant to injectables than oral ED products, but quality systems matter across the board.
• No standardized adverse-event reporting equivalent to the FDA’s MedWatch surveillance for approved drugs.
• No therapeutic interchangeability rating. You cannot assume a compounded 50 mg sildenafil tablet behaves the same way as an FDA-approved 50 mg sildenafil tablet.

The Pharmacy Compounding Accreditation Board (PCAB), operated by the Accreditation Commission for Health Care, accredits compounding pharmacies that voluntarily meet enhanced quality standards. PCAB accreditation is a positive signal but not a substitute for FDA approval.

When compounded ED meds might be reasonable

A balanced answer requires acknowledging legitimate use cases. Compounded ED medication may be a defensible choice when:

• You have a documented allergy or sensitivity to an inactive ingredient (e.g., FD&C Blue No. 2 in Viagra) and your prescriber has reviewed alternatives.
• You need a dose strength not commercially manufactured, with clinical rationale.
• You and your prescriber have specifically decided a chewable or sublingual format addresses an adherence issue.
• You understand the trade-off — lower price and added convenience in exchange for the absence of FDA pre-market review — and choose it with informed consent.

What is harder to defend on clinical grounds: choosing compounded simply because it is cheaper, while assuming it is “the same thing” as an FDA-approved generic. It is not.

How to identify if your ED medication is FDA-approved

Use this checklist when you receive a shipment:

1. Look for an NDC number (National Drug Code) on the bottle or blister pack. Compounded products do not carry NDC numbers.
2. Check the manufacturer label. FDA-approved generics list a recognizable manufacturer (Teva, Mylan/Viatris, Aurobindo, Hikma, Sun Pharma, Camber, etc.).
3. Look for the term “compounded” on the label or paperwork. Federal labeling rules require compounded products to be identified.
4. Review the prescription paperwork. If your prescriber wrote for “compounded sildenafil” or the pharmacy is a 503A/503B facility, the product is compounded.
5. Search the FDA’s Orange Book at accessdata.fda.gov/scripts/cder/ob for the product. Compounded formulations are not listed.
6. Ask the dispensing service directly. A legitimate operator will tell you.

Safer alternatives if you are worried about compounded medications

If you are currently subscribed to a compounded ED service and want to switch to FDA-approved options, you have several straightforward paths:

• Telehealth platforms that dispense FDA-approved generics: Hims (request the generic sildenafil or tadalafil line, not Hard Mints), Ro, and Lemonaid all prescribe FDA-approved generics by default. (CTA placeholder: FDA-approved provider links — Hims generic line, Ro, Lemonaid.)
• GoodRx or Cost Plus Drugs + local pharmacy. Generic sildenafil 20 mg is typically under $20 per month with a discount card.
• Your primary care or urology clinic. A standard PDE5 prescription filled at a major pharmacy chain will always be an FDA-approved product.

If your prescriber has a clinical reason to keep you on a compounded formulation, ask whether the dispensing pharmacy is PCAB-accredited or operates as a 503B outsourcing facility, both of which carry stronger quality assurance signals than a non-accredited 503A.

Related reading on this site:

• BlueChew Review 2026: Is It Still Worth It After the FDA Letter?
• Best Online ED Treatment 2026
• Hims vs BlueChew vs Ro: 2026 Comparison

Live tracker: ED telehealth services and their FDA status (May 2026)

This tracker is updated as we identify new FDA actions, service changes, or product reformulations. Last checked: May 16, 2026.

Frequently asked questions

Are compounded ED meds FDA-approved?

No. Compounded medications — whether produced by 503A traditional compounding pharmacies or 503B outsourcing facilities — are not individually FDA-approved. The FDA does not review the safety or efficacy of compounded formulations before they reach patients. 503B facilities are inspected for manufacturing quality, but the formulations themselves do not undergo new-drug approval.

Is BlueChew safe after the FDA warning?

The September 9, 2025 warning letter to BlueChew’s parent company, Dermacare LLC, alleged marketing violations — specifically, inadequate disclosure that its compounded chewables are not FDA-approved. It is not a recall and not a finding of patient harm. That said, BlueChew’s products remain compounded sildenafil, tadalafil, and vardenafil chewables that have not been individually reviewed by the FDA. Consumers who prefer FDA-approved regulatory assurance should consider generic sildenafil or tadalafil from a service like Hims, Ro, or Lemonaid.

Are Hims Hard Mints compounded?

Yes. Hims’s “Hard Mints” and certain combination products are compounded formulations dispensed under prescription. Hims also offers FDA-approved generic sildenafil and tadalafil as separate product lines — when you sign up, the specific product you receive depends on the formulation selected during the consultation.

What is the difference between generic sildenafil and compounded sildenafil?

Generic sildenafil is an FDA-approved tablet manufactured under CGMP by a company like Teva or Mylan, demonstrated to be bioequivalent to Viagra, and listed in the FDA Orange Book. Compounded sildenafil is a custom formulation prepared by a compounding pharmacy using sildenafil citrate as an active ingredient — it has not been reviewed by the FDA for safety, efficacy, or bioequivalence and is not interchangeable with generic sildenafil from a regulatory standpoint.

Can compounded medications be dangerous?

They can carry risks that FDA-approved medications generally do not, including potency variability, inconsistent quality control, and unverified bulk drug substance sourcing. The most publicized historical incidents involved compounded injectables, not oral ED products. That said, the absence of FDA pre-market review is a meaningful difference for any compounded drug.

Are 503B pharmacies safer than 503A?

503B outsourcing facilities operate under tighter standards — they follow Current Good Manufacturing Practice and are inspected directly by the FDA. They are still not the same as an FDA-approved manufacturer producing an FDA-approved product, but they generally offer stronger quality assurance than non-accredited 503A pharmacies. PCAB accreditation is a useful additional signal for 503A operators.

Should I switch from a compounded ED med?

That is a conversation with your prescriber. If you are doing well on a compounded product, tolerate it, and your clinician has documented a reason for the compounded formulation, switching is not automatically necessary. If you chose compounded primarily for price and you were under the impression it was equivalent to an FDA-approved generic, it is reasonable to ask your prescriber about switching to generic sildenafil or tadalafil.

How do I report a problem with a compounded medication?

Adverse events involving any medication, including compounded products, can be reported to the FDA’s MedWatch program at fda.gov/medwatch. You can also report to your state board of pharmacy, which licenses the compounding facility.

Authoritative sources

• U.S. Food and Drug Administration — Warning Letter: Dermacare LLC dba BlueChew (Sept 9, 2025)
• U.S. Food and Drug Administration — Warning Letter: Hello Cake Inc dba Hello Cake (Sept 9, 2025)
• U.S. Food and Drug Administration — Compounding and the FDA: Questions and Answers
• U.S. Food and Drug Administration — Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
• United States Pharmacopeia — USP Compounding Standards
• National Institutes of Health / MedlinePlus — Sildenafil (Oral Route)
• Pharmacy Compounding Accreditation Board (PCAB) — achc.org/pcab

Medical disclaimer

This article is for general informational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment from a licensed clinician. Erectile dysfunction can be a symptom of underlying cardiovascular, endocrine, or psychological conditions and warrants professional evaluation. Do not start, stop, or change any prescription medication based on information in this article. If you experience an erection lasting more than four hours (priapism), sudden vision or hearing loss, or chest pain after taking a PDE5 inhibitor, seek emergency medical care.

Affiliate disclosure

bestmedshub.com participates in affiliate partnerships with some of the telehealth services discussed in this article, including FDA-approved-generic providers. When you click a partner link and complete a purchase, we may earn a commission at no additional cost to you. Editorial decisions — including which services we cover, how we rate them, and which we recommend — are made independently of commercial relationships. We recommend FDA-approved options as the editorial default regardless of compensation structure.